[Relationship and clinical significance of KiSS-1, nuclear factor kappa B (NF-kappaB), p50, and matrix metalloproteinase 9 expression in breast cancer].
Yi. Xue X; Li. Chang-ying CY; Zhang. Su-hua SH; Wang. Xian-hua XH; Li. Zhan-qing ZQ; Yang. Fang F
Key Findings
- KiSS‑1 (kisspeptin) expression is higher in well‑differentiated breast cancers and drops with tumor aggressiveness and metastasis
- NF‑kB p50 and MMP‑9 levels increase as breast cancer becomes less differentiated, larger, and spreads to lymph nodes
- KiSS‑1 protein levels negatively correlate with NF‑kB p50 and MMP‑9, while NF‑kB p50 and MMP‑9 positively correlate with each other
Practical Outcomes
- For biohackers, this work mainly reinforces that kisspeptin may have anti‑cancer properties, but it offers no dosage, supplement, or protocol guidance. It’s more of a scientific insight than a direct health‑optimization tool, so it isn’t immediately useful for longevity or performance strategies.
Summary
The study looked at how the protein kisspeptin (KiSS-1) and two other molecules, NF‑kB p50 and MMP‑9, appear in breast cancer tissue. It found that higher kisspeptin levels are linked to less aggressive tumors, while NF‑kB and MMP‑9 rise as cancers get worse. The three markers are inversely related, suggesting kisspein may help keep tumors in check, but the research doesn’t give any practical ways to use kisspeptin for health or performance.
Abstract
To study the expression of KiSS-1, nuclear factor kappa B (NF-kappaB) p50 and matrix metalloproteinase 9 (MMP-9) in breast cancer tissue and the relationship with clinicpathological factors. Immunohistochemical staining for KiSS-1, NF-KappaBp50, and MMP-9 protein was performed in 152 cases of human breast tissue [92 cases of BC, 30 cases of epithelial hyperplasia, and 30 cases of peritumoral breast tissue (PMT)] and 54 cases of axillary lymph node metastases. In-situ hybridization for KiSS-1 mRNA was done in 50 cases of breast cancer, and 20 cases of PMT. (1) The expression of KiSS-1 gene was significantly higher in well-differentiated breast cancer than in PMT, and this expression progressively decreased with decreasing degree of tumor differentiation, increasing pathological grade, TNM stage and the presence of lymph node metastases. The expression of KiSS-1 gene in lymph node metastasis was markedly lower than the corresponding primary tumor. There was correlation between the expression of KiSS-1 mRNA and KiSS-1 protein in breast cancer group. (2) The expression of NF-kappaKBp50 and MMP-9 increased progressively with decreasing degree of tumor differentiation, increasing TNM stage, large tumor size ( >2 cm) and the presence of lymph node metastases. The expression of KiSS-1 protein showed negative correlation with that of NF-kappaBp50 and MMP-9 respectively. MMP-9 protein expression was positively correlated with NF-kappap50 protein expression. These suggest that the genes of KiSS-1, NF-kappaBp50 and MMP-9 could be involved in the progression and metastasis of breast cancer.
Study Information
pubmed
2008